Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

PHASE2CompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

February 1, 2014

Primary Completion Date

September 24, 2020

Study Completion Date

September 24, 2020

Conditions
Breast CancerLymphoma
Interventions
DRUG

Atorvastatin

40 mg tablet taken by mouth each morning for 24 months.

DRUG

Placebo

One placebo tablet taken each morning orally for 24 months.

Trial Locations (51)

17822

Geisinger Medical Center, Danville

19104

University of Pennsylvania/Abramson Cancer Center, Philadelphia

20007

MedStar Georgetown University Hospital, Washington D.C.

20010

MedStar Washington Hospital Center, Washington D.C.

22601

Shenandoah Oncology PC, Winchester

23230

Virginia Cancer Institute, Richmond

23298

Virginia Commonwealth University/Massey Cancer Center, Richmond

24501

Centra Lynchburg Hematology-Oncology Clinic Inc, Lynchburg

27103

Novant Health Forsyth Medical Center, Winston-Salem

Novant Health Oncology Specialists, Winston-Salem

27157

Wake Forest University Health Sciences, Winston-Salem

27215

Cone Health Cancer Center at Alamance Regional, Burlington

27284

Novant Health Cancer Institute - Kernersville, Kernersville

27403

Cone Health Cancer Center, Greensboro

28078

Novant Health Cancer Institute - Huntersville, Huntersville

Southern Oncology Specialists-Huntersville, Huntersville

28105

Novant Health Cancer Specialists-Matthews, Matthews

28204

Novant Health Presbyterian Medical Center, Charlotte

28207

Oncology Specialists of Charlotte, Charlotte

28801

Mission Hospital, Asheville

28816

Hope Women's Cancer Centers-Asheville, Asheville

29425

Medical University of South Carolina, Charleston

29605

Prisma Health Cancer Institute - Butternut, Greenville

Prisma Health Cancer Institute - Faris, Greenville

29615

Prisma Health Cancer Institute - Eastside, Greenville

29640

Prisma Health Cancer Institute - Easley, Easley

29672

Prisma Health Cancer Institute - Seneca, Seneca

43015

Delaware Health Center-Grady Cancer Center, Delaware

43214

Columbus Oncology and Hematology Associates Inc, Columbus

43228

Doctors Hospital, Columbus

43701

Genesis Healthcare System Cancer Care Center, Zanesville

48073

William Beaumont Hospital-Royal Oak, Royal Oak

48085

William Beaumont Hospital - Troy, Troy

49503

Spectrum Health at Butterworth Campus, Grand Rapids

53024

Aurora Cancer Care-Grafton, Grafton

53066

Aurora Medical Center in Summit, Summit

53105

Aurora Cancer Care-Southern Lakes VLCC, Burlington

54904

Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh

55101

Regions Hospital, Saint Paul

55102

United Hospital, Saint Paul

55109

Saint John's Hospital - Healtheast, Maplewood

55407

Abbott-Northwestern Hospital, Minneapolis

55416

Park Nicollet Clinic - Saint Louis Park, Saint Louis Park

55905

Mayo Clinic in Rochester, Rochester

60611

Northwestern University, Chicago

60637

University of Chicago Comprehensive Cancer Center, Chicago

67208

Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita

67214

Cancer Center of Kansas - Wichita, Wichita

70121

Ochsner Medical Center Jefferson, New Orleans

90027

Kaiser Permanente Los Angeles Medical Center, Los Angeles

02111

Tufts Medical Center, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT01988571 - Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT) | Biotech Hunter | Biotech Hunter